Related Experiment Video

Updated: May 17, 2026

Determining the Serum Stability of Human Adenosine Deaminase 1 Enzyme
04:17

Determining the Serum Stability of Human Adenosine Deaminase 1 Enzyme

Published on: September 27, 2024

Erythrocytic adenosine deaminase in post myocardial infarction angina patients

Aiki Kaul1, Rishi Sethi, Mithilesh K Misra

  • 1Department of Biochemistry, University of Lucknow, Lucknow, India.

Indian Journal of Clinical Biochemistry : IJCB
|October 30, 2012
PubMed

Insights

Erythrocyte adenosine deaminase and malondialdehyde levels are significantly elevated in patients with post myocardial infarction angina. These findings suggest adenosine deaminase plays a key role in ischemic heart conditions.

Area of Science:

  • Biochemistry
  • Cardiology
  • Clinical Medicine

Background:

  • Myocardial infarction (MI) survivors often experience angina.
  • Biomarkers for assessing cardiac stress and damage are crucial for patient management.
  • Erythrocyte adenosine deaminase (ADA) and lipid peroxidation are implicated in various physiological and pathological processes.

Purpose of the Study:

  • To compare erythrocyte adenosine deaminase (ADA) levels and lipid peroxidation in post-myocardial infarction angina patients versus healthy controls.
  • To investigate the potential role of ADA in ischemic myocardial syndrome.

Main Methods:

  • Comparative study design.
  • Measurement of erythrocyte adenosine deaminase (ADA) activity.
  • Assessment of lipid peroxidation, specifically malondialdehyde (MDA) levels.
  • Inclusion of age and sex-matched healthy individuals as controls.

Main Results:

  • Significantly elevated erythrocyte adenosine deaminase (ADA) levels were observed in post-myocardial infarction angina patients compared to healthy controls.
  • Significantly increased malondialdehyde (MDA) levels, an indicator of lipid peroxidation, were also found in the patient group.
  • A strong correlation between elevated ADA and the presence of ischemic myocardial syndrome is suggested.

Conclusions:

  • Erythrocyte adenosine deaminase (ADA) is a potential biomarker for post-myocardial infarction angina.
  • Elevated lipid peroxidation (MDA) is associated with post-myocardial infarction angina.
  • Adenosine deaminase (ADA) likely has an important implication in the pathophysiology of ischemic myocardial syndrome.

Keywords:
Adenosine deaminaseLipid peroxidationPost MI angina

More Related Videos

Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders05:58

Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders

Published on: February 3, 2021

HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells11:29

HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells

Published on: July 20, 2016

Related Concept Videos

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Antianginal Drugs: Nitrates and β-Blockers01:16

Antianginal Drugs: Nitrates and β-Blockers

In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates,  such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow. Administered...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Angina I: Introduction01:30

Angina I: Introduction

Definition and Symptoms: Angina (angina pectoris) is chest pain or discomfort caused by myocardial ischemia, which occurs when the heart muscle receives insufficient oxygen-rich blood. It typically manifests as pressing, squeezing, or crushing sensations in the chest and may radiate to the shoulders, arms, neck, jaw, or back.Primary Cause: In a healthy state, the coronary arteries can dilate (widen) to increase blood flow and meet the increased oxygen demand during physical activity or...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...